Phacomatosis Pigmentovascularis: Genetic Insights through Cutaneous Pigmentation

Main Article Content

Veronica Martinez Garcia
Lucia Achell Nava
Guadalupe Maldonado Colin
Dolores Maribel Arellano Vivero
Carla Fernandez Reynoso

Abstract

Phacomatosis pigmentovascularis is a group of alterations involving a vascular malformation and a melanocytic lesion, and have diverse clinical cutaneous manifestations, which is the base for the current classification. Furthermore, systemic alterations can occur, including ophthalmological and neurological alterations, some with long term sequalae potential. The case of a 16-day old male patient without previous illness presenting with vascular and pigmented lesions is presented here, with subsequent referral to rule out the most important systemic alterations.

Article Details

How to Cite
Martinez Garcia, V., Achell Nava, L. ., Maldonado Colin, G., Arellano Vivero, D. M., & Fernandez Reynoso, C. (2025). Phacomatosis Pigmentovascularis: Genetic Insights through Cutaneous Pigmentation. International Journal of Medical Science and Clinical Research Studies, 5(3), 475–477. https://doi.org/10.47191/ijmscrs/v5-i03-11
Section
Articles

References

I. James, W. D., Berger, T., & Elston, D. (2025). Andrew’s diseases of the skin. Elsevier Health Sciences. pp. 635

II. Kumar, A., Zastrow, D. B., Kravets, E. J., Beleford, D., Ruzhnikov, M. R. Z., Grove, M. E., Dries, A. M., Kohler, J. N., Waggott, D. M., Yang, Y., Huang, Y., Undiagnosed Diseases Network, Mackenzie, K. M., Eng, C. M., Fisher, P. G., Ashley, E. A., Teng, J. M., Stevenson, D. A., Shieh, J. T., Wheeler, M. T., … Bernstein, J. A. (2019). Extracutaneous manifestations in phacomatosis cesioflammea and cesiomarmorata: Case series and literature review. American journal of medical genetics. Part A, 179(6), 966–977. https://doi.org/10.1002/ajmg.a.61134Kola

III. Kola, B., Mehrafza, M., & Kane, A. (2019). Phacomatosis Pigmentovascularis: Simple Presentation of a Not So Simple Dermatological Condition. Clinical pediatrics, 58(4), 485–487. https://doi.org/10.1177/0009922817737088

IV. Villarreal, D. J., & Leal, F. (2016). Phacomatosis pigmentovascularis of cesioflammea type. Anais brasileiros de dermatologia, 91(5 suppl 1), 54–56. https://doi.org/10.1590/abd1806-4841.20164516

V. Huang, S., Yang, Y., Ouyang, Z., Guo, X., Zhan, Z., Liu, X., Chen, Z., Xu, J., & Yu, M. (2022). The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata. The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata. European journal of dermatology : EJD, 32(5), 589–596. https://doi.org/10.1684/ejd.2022.4317

VI. Torchia D. (2021). Phacomatosis spilorosea versus phacomatosis melanorosea: a critical reappraisal of the worldwide literature with updated classification of phacomatosis pigmentovascularis. Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 30(1), 27–30.

Most read articles by the same author(s)